Clinical Trial Update: Allogeneic Stem Cell Transplantation vs. Conventional Therapy as Salvage Therapy for Relapsed / Progressive Patients With Multiple Myeloma After First-line Therapy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing allogeneic stem cell transplantation versus conventional salvage therapy for relapsed or progressive multiple myeloma after fir…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: Universitätsklinikum Hamburg-Eppendorf | Conditions: Multiple Myeloma | Phase 3 | Status: TERMINATED